1. Editor-in-Chief’s Commentary: Integrating Economics Into Innovation

   • Stephen P. Spielberg

   Commentary 30 December 2013 Pages: 395 - 396

2. Improving Good Practice: A Survey of Unlicensed and Off-Label Drug Use in a General Hospital in China

   • Hanbin Wu
   • Gao Wu

   Global Perspectives 30 December 2013 Pages: 397 - 404

3. The Regulation of Companion Diagnostics: A Global Perspective

   • Maham Ansari

   Global Perspectives 30 December 2013 Pages: 405 - 415

4. Supplement Use Among Pregnant Women in Ethiopia: Prevalence and Predictors

   • Mohammed Adem Mohammed
   • Abdulhalik workicho Bushra
   • Jemal Hussein Ahmed

   Global Perspectives 30 December 2013 Pages: 416 - 423

5. Good Laboratory Practice Inspections in Japan Between Fiscal Years 2009–2011

   • Reiko Anahara

   Global Perspectives 30 December 2013 Pages: 424 - 429

6. Investigation of Characteristics of Japanese Clinical Trials in Terms of Data Variability

   • Kazuhiro Kanmuri
   • Mamoru Narukawa

   Global Perspectives 30 December 2013 Pages: 430 - 437

7. Sample Size and Data Monitoring for Clinical Trials With Extremely Low Incidence Rates

   • Shein-Chung Chow
   • Shih-Ting Chiu

   Clinical Trials 30 December 2013 Pages: 438 - 446

8. A Framework for Managing the Minimal Clinically Important Difference in Clinical Trials

   • Denitsa Koynova
   • Reinhold Lühmann
   • Renate Fischer

   Clinical Trials 30 December 2013 Pages: 447 - 454

9. Analysis Sets and Inference in Clinical Trials

   • Gerd K. Rosenkranz

   Clinical Trials 30 December 2013 Pages: 455 - 459

10. Blinded Sample Size Recalculation in Longitudinal Clinical Trials Using Generalized Estimating Equations

    • Daniel Wachtlin
    • Meinhard Kieser

    Clinical Trials 30 December 2013 Pages: 460 - 467

11. Understanding the Diagnosis and Treatment of COPD and Asthma to Better Inform Site Selection and Patient Recruitment Planning

    • Neil Leslie
    • I-Shan Chiang
    • Prasad Velisetty

    Clinical Trials 30 December 2013 Pages: 468 - 473

12. Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug Development

    • Lynn G. Baird
    • Mark R. Trusheim
    • Gigi Hirsch

    Drug Development 30 December 2013 Pages: 474 - 483

13. Search Strategies Used for Meta-Analyses Published on Cardiovascular Drug Therapy

    • Drew L. Armstrong
    • Katie J. Suda
    • Lin Wu

    Drug Development 30 December 2013 Pages: 484 - 488

14. Pharmacotherapeutic Follow-up and Pharmacogenetics of CYP2C9 and CYP3A4 in Antihypertensive Therapy: A Pilot Study in a Community Pharmacy

    • María Jesús Rodríguez-Arcas
    • Emilio García-Jiménez
    • Pablo Conesa-Zamora

    Pharmacotherapy 30 December 2013 Pages: 489 - 494

15. Views on Emerging Issues Pertaining to Data Monitoring Committees for Adaptive Trials

    • Zoran Antonijevic
    • Paul Gallo
    • Matilde Sanchez

    Adaptive Trials 30 December 2013 Pages: 495 - 502

16. DIA 2013 49th Annual Meeting Student Poster Abstracts

    DIA 2013 Student Poster Abstracts 30 December 2013 Pages: 503 - 513